Prescription medication · Selective Serotonin Reuptake Inhibitor (SSRI)

escitalopram

Also sold as Lexapro. Escitalopram is used to treat major depressive disorder (MDD) in adults and children 12 years and older.

Data updated 2026-05-15

134,536
FDA reportsHeavily reported
12
InteractionsSeveral interactions
99% less
Generic vs brandHuge savings
$14.05
Brand price (NADAC)

What the data shows

escitalopram (Lexapro) is a prescription Selective Serotonin Reuptake Inhibitor (SSRI), more reported than roughly 9 in 10 tracked drugs (134,536 FDA reports), whose generic costs a fraction of the brand (about 99% less).

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

escitalopram (Lexapro) is a prescription Selective Serotonin Reuptake Inhibitor (SSRI). Escitalopram is used to treat major depressive disorder (MDD) in adults and children 12 years and older.

Escitalopram is a medicine used to treat depression and anxiety. It helps to balance chemicals in your brain.

Drug Pricing (NADAC)

Brand Price

$14.05/unit

Generic Price

$0.04/unit

Generic Savings

99%

Generic Available

Yes (17 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

View Alternatives → Compare with Another Drug → Full Side Effects Report →

What it does

Escitalopram is used to treat major depressive disorder (MDD) in adults and children 12 years and older.

Common side effects

Trouble sleeping (insomnia), Problems with ejaculation (mostly delayed ejaculation), Feeling sick to your stomach (nausea)

Key warnings

Antidepressants can increase the risk of suicidal thoughts and behaviors in children, teenagers, and young adults.

The sections below are summarized in plain English from escitalopram's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Escitalopram is a selective serotonin reuptake inhibitor (SSRI). It works by increasing the amount of serotonin in your brain. Serotonin is a chemical that helps regulate mood.

Side Effects (from patient reports)

Based on 134,536 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for escitalopram, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for escitalopram each year to the FDA Adverse Event Reporting System (FAERS).

05,00010,00015,000 200320062009201220152018202120242025 8,981

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where escitalopram sits

escitalopram has more FDA adverse-event reports than 91% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is escitalopram; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 134,536 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2003–2025.

Total Reports

134,536

Reports Mentioning Death

10,908

8.1% of reports — not proof of cause

Hospitalization Reports

42,595

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 85,584 (69%)
Male 38,533 (31%)

Age Distribution

0–17 3,803
18–44 25,461
45–64 31,873
65–74 14,641
75+ 13,300

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 FATIGUE 9,196
2 NAUSEA 9,164
4 HEADACHE 7,114
5 DIARRHOEA 6,709
6 ANXIETY 6,447
7 DIZZINESS 6,087
8 DEPRESSION 5,978
10 PAIN 5,646
11 FALL 5,401
12 DYSPNOEA 5,273
13 VOMITING 5,090
14 INSOMNIA 4,377
15 ASTHENIA 4,355
16 SOMNOLENCE 3,953
17 CONDITION AGGRAVATED 3,892

Reactions in Death Reports

DEATH 3,121
COMPLETED SUICIDE 2,477
TOXICITY TO VARIOUS AGENTS 869
CARDIO-RESPIRATORY ARREST 692
DYSPNOEA 633
FALL 574
FATIGUE 544
CARDIAC ARREST 532
ASTHENIA 516
NAUSEA 496

Reactions in Hospitalization Reports

FALL 3,035
NAUSEA 2,957
DYSPNOEA 2,659
FATIGUE 2,406
DIARRHOEA 2,372
VOMITING 2,323
ANXIETY 2,251
PNEUMONIA 2,233
ASTHENIA 2,021
DEPRESSION 2,016

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Antidepressants can increase the risk of suicidal thoughts and behaviors in children, teenagers, and young adults. Watch closely for worsening depression or suicidal thoughts. Escitalopram is not approved for use in children younger than 7 years old.

Known Drug Interactions

7 DRUG INTERACTIONS Table 6 presents clinically important drug interactions with escitalopram. TABLE 6 Clinically Important Drug Interactions with Escitalopram Monoamine Oxidase Inhibitors (MAOIs) Clinical Impact: Concomitant use of SSRIs, including escitalopram, and MAOIs increases the risk of serotonin syndrome. Intervention: Escitalopram is contraindicated in patients taking MAOIs, including MAOIs such as linezolid or intravenous methylene blue [ see Dosage and Administration (2.7) , Contraindications (4) , and Warnings and Precautions (5.2) ] Pimozide Clinical Impact: Concomitant use...

Mechanism: These two drugs are nearly identical, so taking them together is like taking a double dose of the same medicine.

Intervention: Escitalopram is contraindicated in patients taking MAOIs, including MAOIs such as linezolid or intravenous methylene blue [ see Dosage and Administration (2.7) , Contraindications (4) , and Warnings and Precautions (5.2) ] Pimozide Clinical Impact: Concomitant use of racemic citalopram with pimozide increases plasma concentrations of pimozide, a drug with a narrow therapeutic index, and may increase the risk of QT prolongation and/or ventricular arrhythmias compared to use of racemic citalopram alone [ see Clinical Pharmacology (12.3) ].

Mechanism: Linezolid acts as a special type of medicine that stops the body from clearing serotonin, which can cause a dangerous reaction when mixed with escitalopram.

Intervention: Escitalopram is contraindicated in patients taking MAOIs, including MAOIs such as linezolid or intravenous methylene blue [ see Dosage and Administration (2.7) , Contraindications (4) , and Warnings and Precautions (5.2) ] Pimozide Clinical Impact: Concomitant use of racemic citalopram with pimozide increases plasma concentrations of pimozide, a drug with a narrow therapeutic index, and may increase the risk of QT prolongation and/or ventricular arrhythmias compared to use of racemic citalopram alone [ see Clinical Pharmacology (12.3) ]. Intervention: Escitalopram is...

Mechanism: Escitalopram raises the amount of pimozide in your blood, which can cause dangerous heart rhythm issues.

moderate aspirin

If serotonin syndrome occurs, consider discontinuation of escitalopram and/or concomitant serotonergic drugs [ see Warnings and Precautions(5.2) ] Drugs That Interfere With Hemostasis (NSAIDs, Aspirin, Warfarin, etc.) Clinical Impact: Concomitant use of escitalopram and an antiplatelet or anticoagulant may potentiate the risk of bleeding. Concomitant use with SSRIs, SNRIs or Tryptophan is not recommended ( 7 ) Use caution when concomitant use with drugs that affect Hemostasis (NSAIDs, Aspirin, Warfarin) ( 7 )

Mechanism: Escitalopram can interfere with how blood cells stick together, and aspirin also thins the blood. Combining them makes it much more likely that you will experience bleeding or bruising.

moderate warfarin

If serotonin syndrome occurs, consider discontinuation of escitalopram and/or concomitant serotonergic drugs [ see Warnings and Precautions(5.2) ] Drugs That Interfere With Hemostasis (NSAIDs, Aspirin, Warfarin, etc.) Clinical Impact: Concomitant use of escitalopram and an antiplatelet or anticoagulant may potentiate the risk of bleeding. For patients taking warfarin, carefully monitor the internationalnormalized ratio [ see Warnings and Precautions (5.7) ]. Concomitant use with SSRIs, SNRIs or Tryptophan is not recommended ( 7 ) Use caution when concomitant use with drugs that affect...

Mechanism: This combination increases your risk of bleeding because both drugs affect how your blood clots. Escitalopram can also change how your body responds to the blood thinner.

Check all your medications →

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

Can I stop taking escitalopram suddenly?
No, you should not stop taking escitalopram suddenly. Talk to your doctor about slowly reducing the dose to avoid withdrawal symptoms.
Can escitalopram cause weight gain?
Weight changes are possible with escitalopram, but it varies from person to person. Talk to your doctor if you are concerned.
Can I drink alcohol while taking escitalopram?
It is best to avoid alcohol while taking escitalopram, as it can worsen side effects.
How long does it take for escitalopram to work?
It may take several weeks for you to feel the full effects of escitalopram.
What should I do if I experience side effects?
Talk to your doctor about any side effects you experience while taking escitalopram.
Can escitalopram be used for other conditions?
Escitalopram is primarily used for depression and anxiety, but your doctor may have other reasons for prescribing it.
Is it safe to take escitalopram with other medications?
Tell your doctor about all the medications you take, including over-the-counter drugs and supplements.
What if I feel worse after starting escitalopram?
Contact your doctor immediately if you feel worse or have any suicidal thoughts.
Does escitalopram interact with any foods?
Escitalopram can be taken with or without food.
How often will I see my doctor while taking escitalopram?
Your doctor will schedule regular checkups to monitor your progress and side effects.
What are the common side effects of escitalopram?
The registry lists Trouble sleeping (insomnia), Problems with ejaculation (mostly delayed ejaculation), Feeling sick to your stomach (nausea), Increased sweating, Feeling tired (fatigue) among the most-reported FAERS reaction terms for escitalopram. The compiled record contains 134,536 FDA adverse-event reports. These counts are not an individual symptom assessment.
Does escitalopram interact with other medications?
The registry has 12 documented interaction rows for escitalopram. Notable source-record pairings include citalopram, linezolid, pimozide. These rows are not a complete medication review.
What drug class is escitalopram?
escitalopram belongs to the Selective Serotonin Reuptake Inhibitor (SSRI) drug class. It requires a prescription (Rx). Escitalopram is used to treat major depressive disorder (MDD) in adults and children 12 years and older.
Is there a generic version of escitalopram?
Yes, generic escitalopram is available from 17 manufacturers. The generic costs $0.04 per unit compared to $14.05 for the brand version, saving approximately 99%. Pricing is based on NADAC (National Average Drug Acquisition Cost) data from CMS.
What pregnancy or breastfeeding source fields are listed for escitalopram?
The FDA label for escitalopram contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.

Other drugs grouped near escitalopram - same-class peers and common alternatives.

Compare escitalopram vs acamprosate side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for escitalopram: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

Save on escitalopram

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for escitalopram

The FDA label for escitalopram (sold under brand names such as Lexapro) classifies it as a prescription-only medication in the Selective Serotonin Reuptake Inhibitor (SSRI) class. Escitalopram is used to treat major depressive disorder (MDD) in adults and children 12 years and older. Official labeling lists 8 commonly reported side effects, including Trouble sleeping (insomnia), Problems with ejaculation (mostly delayed ejaculation), Feeling sick to your stomach (nausea).

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 134,536 voluntary reports. The database also lists 12 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. NADAC pricing from CMS shows a generic unit cost of $0.04 versus $14.05 for the brand - a 99% generic savings.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: March 5, 2025

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page